The European Fee secured an extra 200 million doses of the BioNTech-Pfizer vaccine, with the choice of an additional 100 million. In complete, 600 million doses of this vaccine will probably be accessible for member states. The extra doses will probably be delivered within the second quarter of 2021. BioNTech-Pfizer and Moderna vaccines are the one jabs authorised within the EU. The EU sealed offers for as much as 2.3 billion vaccine doses.